IL6R
Interleukin-6 receptor subunit alpha
Also known as: CD126, gp80, IL-1Ra, IL-6R, IL6RA, IL6RA_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P08887
- Gene
- IL6R
- Ensembl
- ENSG00000160712
- Chromosome
- 1
- Canonical length
- 468 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a subunit of the interleukin 6 (IL6) receptor complex. Interleukin 6 is a potent pleiotropic cytokine that regulates cell growth and differentiation and plays an important role in the immune response. The IL6 receptor is a protein complex consisting of this protein and interleukin 6 signal transducer (IL6ST/GP130/IL6-beta), a receptor subunit also shared by many other cytokines. Dysregulated production of IL6 and this receptor are implicated in the pathogenesis of many diseases, such as multiple myeloma, autoimmune diseases and prostate cancer. Alternatively spliced transcript variants encoding distinct isoforms have been identified in this gene. A pseudogene of this gene is found on chromosome 9. [provided by RefSeq, Aug 2020]
Canonical amino-acid sequenceUniProt
468 residues, UniProt reviewed canonical sequence.
>P08887|IL6R
1 MLAVGCALLA ALLAAPGAAL APRRCPAQEV ARGVLTSLPG DSVTLTCPGV EPEDNATVHW
61 VLRKPAAGSH PSRWAGMGRR LLLRSVQLHD SGNYSCYRAG RPAGTVHLLV DVPPEEPQLS
121 CFRKSPLSNV VCEWGPRSTP SLTTKAVLLV RKFQNSPAED FQEPCQYSQE SQKFSCQLAV
181 PEGDSSFYIV SMCVASSVGS KFSKTQTFQG CGILQPDPPA NITVTAVARN PRWLSVTWQD
241 PHSWNSSFYR LRFELRYRAE RSKTFTTWMV KDLQHHCVIH DAWSGLRHVV QLRAQEEFGQ
301 GEWSEWSPEA MGTPWTESRS PPAENEVSTP MQALTTNKDD DNILFRDSAN ATSLPVQDSS
361 SVPLPTFLVA GGSLAFGTLL CIAIVLRFKK TWKLRALKEG KTSMHPPYSL GQLVPERPRP
421 TPVLVPLISP PVSPSSLGSD NTSSHNRPDA RDPRSPYDIS NTDYFFPRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL6R can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 91 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 91 nTPM
- liver: 59 nTPM
- lymph node: 26 nTPM
- tongue: 25 nTPM
- appendix: 24 nTPM
- tonsil: 21 nTPM
Single-cell type
- neutrophils: 773 nCPM
- monocytes: 308 nCPM
- proximal tubule cells: 305 nCPM
- hepatocytes: 260 nCPM
- endometrial glandular cells: 213 nCPM
- neutrophil progenitors: 206 nCPM
Immune cell
- neutrophil: 89 nTPM
- myeloid DC: 36 nTPM
- classical monocyte: 30 nTPM
- eosinophil: 28 nTPM
- T-reg: 22 nTPM
- intermediate monocyte: 18 nTPM
Brain region
- cerebral cortex: 30 nTPM
- medulla oblongata: 30 nTPM
- thalamus: 28 nTPM
- white matter: 28 nTPM
- spinal cord: 28 nTPM
- pons: 27 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IL6R.
Disease | AllUniProt
Conditions IL6R is implicated in, by any mechanism.
- Hyper-IgE syndrome 5, autosomal recessive, with recurrent infections (HIES5) MIM:618944
ReferencesPubMed · IEDB
Publications for IL6R from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
13 publications
- Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C).
2020 · Cell · RCR 21.6 · 459 citations - Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica.
2011 · Proc Natl Acad Sci U S A · RCR 10.2 · 372 citations - IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis.
2008 · Proc Natl Acad Sci U S A · RCR 6.2 · 280 citations - Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression.
1992 · Clin Exp Immunol · RCR 2.9 · 124 citations - IL-6 receptor antibody treatment improves muscle weakness in experimental autoimmune myasthenia gravis mouse model.
2024 · Front Neurol · RCR 1.9 · 10 citations
Show 8 more
- Monoclonal anti-interleukin-6 receptor antibody attenuates donor-specific antibody responses in a mouse model of allosensitization.
2013 · Transpl Immunol · RCR 1.4 · 47 citations - Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C).
2020 · medRxiv · RCR 0.9 · 22 citations - Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis.
2010 · Hepatology · RCR 0.6 · 25 citations - IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
2015 · Mod Rheumatol · RCR 0.5 · 15 citations - Correlation of interleukin-6 and monocyte chemotactic protein-1 concentrations with crescent formation and myeloperoxidase-specific anti-neutrophil cytoplasmic antibody titer in SCG/Kj mice by treatment with anti-interleukin-6 receptor antibody or mizoribine.
2013 · Microbiol Immunol · RCR 0.2 · 8 citations - Anti-IL-6 receptor antibody suppresses onset of paralytic symptoms in AQP4 peptide-immunized mice without lowering bone strength or mineral density.
2025 · J Neuroimmunol · 1 citations - Anti-IL-6R antibody treatment changes microglial phenotype in AQP4 peptide-immunized mice, leading to suppression of myelitis severity.
2025 · J Neuroimmunol · 1 citations - The role of monoclonal antibodies against IL-6 or IL-6R in the treatment of thyroid eye disease.
2026 · Rev Endocr Metab Disord
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.81
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.69
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- acute-phase response
- cell surface receptor signaling pathway via STAT
- ciliary neurotrophic factor-mediated signaling pathway
- cytokine-mediated signaling pathway
- defense response to Gram-negative bacterium
- defense response to Gram-positive bacterium
- endocrine pancreas development
- extrinsic apoptotic signaling pathway
- hepatic immune response
- interleukin-6-mediated signaling pathway
- monocyte chemotaxis
- negative regulation of collagen biosynthetic process
- negative regulation of interleukin-8 production
- neutrophil mediated immunity
- positive regulation of cell population proliferation
- positive regulation of chemokine production
- positive regulation of glomerular mesangial cell proliferation
- positive regulation of interleukin-6 production
- positive regulation of leukocyte chemotaxis
- positive regulation of MAPK cascade
- positive regulation of osteoblast differentiation
- positive regulation of smooth muscle cell proliferation
- response to cytokine
- T-helper 17 cell lineage commitment
- vascular endothelial growth factor production
Molecular functions
- cytokine receptor activity
- enzyme binding
- interleukin-11 binding
- interleukin-11 receptor activity
- interleukin-6 receptor activity
- protein homodimerization activity
- ciliary neurotrophic factor binding
- interleukin-6 binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Long hematopoietin receptor, soluble alpha chain, conserved site
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Fibronectin type III
- Immunoglobulin-like domain
- Immunoglobulin-like beta-sandwich domain
- Immunoglobulin-like fold
- Type I cytokine receptor, cytokine-binding domain
- Fibronectin type III superfamily
- Immunoglobulin-like domain superfamily
- Immunoglobulin domain
- Interleukin-6 receptor alpha chain, binding
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IL6R in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL6R as an antibody target. Whether an autoantibody or antibody against IL6R could matter depends on whether native IL6R is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL6R is annotated at the cell surface, where native IL6R is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- Dysregulated production of IL6 and this receptor are implicated in the pathogenesis of many diseases, such as multiple myeloma, autoimmune diseases and prostate cancer.
Loading the interactive Seroatlas protein explorer...